Condition
TB Infection
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Not Yet Recruiting2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07647107Phase 1Not Yet Recruiting
A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations
NCT07520448Not ApplicableNot Yet Recruiting
Prevention and Mass Screening of TB in Prisons in Paraguay
NCT07164742Not ApplicableRecruiting
Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)
NCT06221735Not ApplicableCompleted
Evaluating the Accuracy of New Tests for TB Infection Diagnosis
Showing all 4 trials